Business Wire

Recipients of HCL GRANT 2019 Felicitated by Amitabh Kant & Sourav Ganguly

Jaa

Mr. Amitabh Kant, CEO, Niti Aayog and Mr. Sourav Ganguly, Former captain of the Indian National Cricket Team felicitated the winners of HCL Grant 2019 at a ceremony held today at HCL Technologies Campus, Noida, in the presence of Mr. Shiv Nadar, Founder & Chairman, HCL, Ms. Roshni Nadar Malhotra, Vice Chairperson, HCL Technologies and Chairperson, CSR Committee, HCL Technologies, along with senior dignitaries, bureaucrats, NGO-partners and the HCL leadership.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190221005822/en/

L to R - Ms. Roshni Nadar Malhotra, Vice Chairperson, HCL Technologies and Chairperson, CSR Committe ...

L to R - Ms. Roshni Nadar Malhotra, Vice Chairperson, HCL Technologies and Chairperson, CSR Committee, HCL Technologies; Mr. Sourav Ganguly, Former Captain of Indian National Cricket Team; Mr. Amitabh Kant, CEO, NITI Aayog and Ms. Robin Abrams, former president of Palm Computing and longest-serving Board member of HCL Technologies along with the HCL Grant 2019 recipients - Environment - Wildlife Trust of India; Health - She Hope Society for Women Entrepreneurs and Education - Srijan Foundation. (Photo: Business Wire)

One of the biggest and most coveted institutionalized CSR grants of India, HCL Grant recognizes the rise of community-led ecosystems of NGOs. Three NGOs across the categories of Education, Healthcare and Environment received a grant of ₹5 crore each. This year, HCL Grant also introduced an additional grant of ₹25 lakhs each for the six finalists across the three categories, taking the overall Grant purse to ₹16.5 crore. During the event, the third edition of the “The Fifth Estate - NGOs transforming Rural India in Environment, Health and Education” was also released.

The recipients of HCL Grant 2019 are:

  • Health – The 2019 HCL Grant winner in this category is She Hope Society for Women Entrepreneurs. Established in 2001, the organization is working in remote, border and isolated areas of Jammu and Kashmir on Physical Rehabilitation.
    • Project Title: Humanitarian assistance to strengthen inclusion and safety of vulnerable persons especially women and children in conflict affected areas of Jammu and Kashmir.
    • Project Location: 4 Districts of Jammu & Kashmir (Kupwara, Baramulla, Rajouri and Poonch)
  • Environment – Wildlife Trust of India is the winner of HCL Grant 2019 in the Environment category. WTI has been working towards wildlife and biodiversity conservation issues across the country since 1999.
    • Project Title: Connecting Landscapes, Empowering People and Protecting Elephants- An initiative to secure the Baghmara - Balpakram Elephant corridor and protect the wildlife habitats of Garo Hills, Meghalaya.
    • Project Location: Garo Hills, Meghalaya.
  • Education – The winner for HCL Grant 2019 in the Education category is Srijan Foundation. Established in 2001, the Srijan Foundation aims to work for the welfare of the underprivileged by building capacity of the community as well as grass root organizations.
    • Project Title: Educating the Women Farmers for better Livelihood Opportunities and better Income Generation.
    • Project Location: Hazaribagh & West Singhbhum in Jharkhand

Mr. Amitabh Kant said, “HCL has put together a great model to support the country’s development agenda. I congratulate the winners and the finalists for their sincere work and wish them all the best.”

Mr. Sourav Ganguly, Former Captain of Indian National Cricket Team, said, “I feel privileged to be a part of this event. It is inspiring to see the work of the NGOs and I congratulate the winners of HCL Grant and HCL for the outstanding work they are doing.”

Ms. Nidhi Pundir, Director-CSR and Head-HCL Foundation, said, “Over the course of four years, HCL Grant has enabled the emergence of a cadre of remarkable community-based, participatory NGOs that are strengthening grassroots development by driving deeper and wider impact.”

“HCL Grant is a path-breaking initiative towards recognizing and supporting the inspiring work done by NGOs in three key development categories in India,” said Ms. Robin Abrams, former president of Palm Computing and longest-serving Board member of HCL Technologies.

Till date, HCL Grant has committed ₹35 crore (US$5.4 million) towards rural development with an ambition to reach over 900,000 people. Today, the seven HCL Grant recipients are addressing some of the most pressing issues in the remotest corners of the country with innovative solutions – creating the last mile support framework. Since 2015, HCL Grant projects have already significantly altered over 3,70,000 lives in 3500 villages across 26 districts in 12 states of India.

This year witnessed an overwhelming response from over 4000 applicants. The applications were carefully scrutinized through a robust 8-month long process, monitored and audited by Governance Partner, Grant Thornton.

About HCL Grant - www.hclfoundation.org/hcl-grant and About HCL Tech - https://www.hcltech.com/

Contact information

For more information contact: Siddhartha Bhatnagar - bhatnagars@hcl.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis25.3.2019 23:30:00 EETTiedote

Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (RMS). Ozanimod is an oral, sphingosine 1-phosphate (S1P) receptor modulator, which binds with high affinity selectively to S1P subtypes 1 (S1P1) and 5 (S1P5). The pivotal efficacy and safety data provided in the application result from the SUNBEAM™ and RADIANCE™ Part B phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled trials. “New oral treatment options with differentiated profiles like ozanimod are needed to help address an unmet need for people with relapsing forms of MS,” said Jay Backstrom, M.D., Chief Medical Officer for Celgene. “With concurrent applications in the U.S. and EU, we look forward to advancing this promising medicine through the regulatory review process to provide a new option for the treatment of RMS in

AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia25.3.2019 22:50:00 EETTiedote

Associazione Veneta Lotta alla Talassemia (AVLT) and the UK Thalassaemia Society (UKTS) announced today that the European Medicines Agency (EMA) has approved bluebird bio’s application for Conditional Marketing Authorization (cMAA) of their product Zynteglo™, a gene therapy for the treatment of adolescents and adults with transfusion-dependent β-thalassaemia (TDT) who do not have a β0/β0 genotype. As a result of this marketing authorisation, Zynteglo™ is now approved for use in all European countries covered by the European Medicines Agency. Zynteglo™ has been given ‘conditional authorisation’. This means that there is more evidence to be submitted, which the company is required to provide under specific obligations. Every year, the EMA will review any new information that becomes available. “People living with transfusion-dependent β-thalassaemia have a reduced life expectancy, requiring life-long frequent blood transfusions that are life-saving but may lead to complications, includin

Historic Partnership between the Weizmann Institute of Science and Institut Curie25.3.2019 19:54:00 EETTiedote

On March 22, the Weizmann Institute of Science in Rehovot, Israel, and Institut Curie in Paris, France, two major world-class research institutes, signed an historic partnership that will allow their teams to work closely together to improve knowledge in the field of life sciences, particularly in the areas of physics and chemistry, and most specifically - in the field of cancer research. This is a milestone in the history of these two institutes that have been working together for 15 years, particularly in the field of biophysics. Collaborative research programs This partnership will extend to many disciplines, including physics, chemistry, cellular biology, epigenetics, genetics, immunology and single cell approaches, imagery and data collection. The complementarity of the research between the various groups at Institut Curie and at the Weizmann Institute has been recognized in particular at the occasion of joint scientific workshops held regularly alternatively in Paris and Rehovot.

Bidgely EV Solution Detects Charging Patterns for Vehicle-to-Grid Integration25.3.2019 19:36:00 EETTiedote

Bidgely today introduced an Electric Vehicle (EV) Solution for global utilities that applies artificial intelligence and machine learning to customer data for smart vehicle-to-grid (V2G) integration. With Bidgely’s industry-leading EV disaggregation patent serving as the foundation, the new EV Solution identifies territory-wide residential charging patterns and pinpoints homes with EVs for targeted product and service offerings that help utilities enhance customer engagement, manage the grid more effectively and generate new revenue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190325005621/en/ The new Bidgely EV Solution identifies territory-wide residential charging patterns and pinpoints homes with EVs for targeted product and service offerings that help utilities enhance customer engagement, manage the grid more effectively and generate new revenue. (Graphic: Business Wire) “Beneficial electrification, and EVs in parti

The International Society for Quality in Health Care Partners with the Patient Safety Movement Foundation to Achieve Zero Preventable Deaths in Hospitals25.3.2019 19:30:00 EETTiedote

The International Society for Quality in Health Care (ISQua) is pleased to announce their support of the Patient Safety Movement Foundation (PSMF) and their mission to eliminate preventable deaths in hospitals, with a signed cooperation agreement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190325005265/en/ With this agreement, ISQua and PSMF agree to work together to further their aims to improve quality and safety in healthcare and eliminate preventable patient deaths. The partnership will provide synergy so that our missions can be amplified. ISQua and PSMF will work together to identify common projects in the field of patient safety and promote each other’s activities on an ongoing basis. ISQua and PSMF will hold joint sessions at their respective conferences, at ISQua’s 36th International Conference (20th – 23rd October 2019) in Cape Town, South Africa; and PSMF’s 8th Annual World Patient Safety, Science & Technology

The Results Are In! BOC Group Named a Leader in the Enterprise Architecture Management Suites, Q1 2019 report by Independent Research Firm25.3.2019 16:32:00 EETTiedote

BOC Group, the leading global provider of Enterprise Management Solutions, announced today that it has been recognized as a “Leader” in The Forrester Wave™: Enterprise Architecture Management Suites, Q1 2019 report. Evaluated against 35 rigorous criteria, BOC Group’s EA suite ADOIT received the highest possible scores in 16 of them, including customer satisfaction, innovation agenda criteria and many others! Christoph Moser, ADOIT product manager, comments on this accomplishment by saying: “We see this achievement as an affirmation of our unwavering position as a front-runner in the EA industry and a direct reflection of the strength, depth and breadth we have incorporated across all aspects of our comprehensive, user-centric EA offering and portfolio in the last years.” Moser continues: “For us, this recognition is hard-earned and well deserved. But more importantly, we believe it further proves our strategy, relentless commitment to our customers, and continued mission to enable orga

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme